Peter Petrow
About
In The Last Decade
Peter Petrow
78 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Obstetrics and Gynecology 2.5k
- Surgery 1.9k
- Radiation 1.1k
- Epidemiology 880
- Oncology 877
Countries citing papers authored by Peter Petrow
This map shows the geographic impact of Peter Petrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Petrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Petrow more than expected).
Fields of papers citing papers by Peter Petrow
This network shows the impact of papers produced by Peter Petrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Petrow. The network helps show where Peter Petrow may publish in the future.
Co-authorship network of co-authors of Peter Petrow
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Petrow. A scholar is included among the top collaborators of Peter Petrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Petrow. Peter Petrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin breakdown → | 334 |
| 2 | 54 | |
| 3 | 12 | |
| 4 | 2 | |
| 5 | 71 | |
| 6 | Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GEC ESTRO GYN working group delineation workshops | 8 |
| 7 | Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV breakdown → | 1152 |
| 8 | 37 | |
| 9 | Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC-ESTRO study protocol | 3 |
| 10 | Application of GEC-ESTRO recommendations on reporting 3D image based cervix cancer brachytherapy - Intercomparison of MR based treatment approaches in 3 different institutions | 0 |
| 11 | 62 | |
| 12 | 17 | |
| 13 | 45 | |
| 14 | Brachytherapy in cervix cancers: techniques and concepts evolution | 2 |
| 15 | Tularemia — First Cases of Oculoglandular Form of the Disease in Bulgaria | 3 |
| 16 | 236 | |
| 17 | 20 | |
| 18 | Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles. | 7 |
| 19 | 3 | |
| 20 | Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. | 125 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.